BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Basu S, Naha A, Veeraraghavan B, Ramaiah S, Anbarasu A. In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. J Cell Biochem 2021. [PMID: 33998043 DOI: 10.1002/jcb.29953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Basu S, Joshi SM, Ramaiah S, Anbarasu A. Designing Anti-Microbial Peptides Against Major β-Lactamase Enzymes in Clinically Important Gram-Negative Bacterial Pathogens: An In-Silico Study. Probiotics & Antimicro Prot . [DOI: 10.1007/s12602-022-09929-1] [Reference Citation Analysis]
2 Varghese R, Basu S, Neeravi A, Pragasam A, Aravind V, Gupta R, Miraclin A, Ramaiah S, Anbarasu A, Veeraraghavan B. Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges. Front Microbiol 2021;12:810414. [PMID: 35185834 DOI: 10.3389/fmicb.2021.810414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shankar C, Basu S, Lal B, Shanmugam S, Vasudevan K, Mathur P, Ramaiah S, Anbarasu A, Veeraraghavan B. Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence. Front Cell Infect Microbiol 2021;11:709681. [PMID: 34589442 DOI: 10.3389/fcimb.2021.709681] [Reference Citation Analysis]
4 Miryala SK, Basu S, Naha A, Debroy R, Ramaiah S, Anbarasu A, Natarajan S. Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: A molecular docking and molecular dynamics simulation study. Journal of Molecular Liquids 2021;341:117340. [DOI: 10.1016/j.molliq.2021.117340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Naha A, Vijayakumar S, Lal B, Shankar BA, Chandran S, Ramaiah S, Veeraraghavan B, Anbarasu A. Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam-durlobactam holds promise for therapeutic intervention. J Cell Biochem 2021. [PMID: 34597421 DOI: 10.1002/jcb.30156] [Reference Citation Analysis]